August 10, 2009American Journal of Health-System Pharmacy

Intravenous therapy for hypertensive emergencies, part 2

View Full Paper

Ask AI

Bookmark

Population

Patients with hypertensive emergency

Design

Review

Authors

DRDenise H. RhoneyUniversity of North Carolina at Chapel Hill WPW. Frank PeacockBaylor College of Medicine

Discussion

Member takes

Implication

Emphasizes pharmacology- and comorbidity-driven IV antihypertensive choice in hypertensive emergencies; leaves open definitive outcome data from randomized studies.

Structured PICO

Population

Patients with hypertensive emergency

Intervention

Intravenous antihypertensive agents (nicardipine, nitroprusside, fenoldopam, nitroglycerin, enalaprilat, hydralazine, labetalol, esmolol, phentolamine, clevidipine)

Outcome

Rapid controlled reduction of blood pressure to prevent or minimize end-organ damage

Rapid recognition and tailored selection of intravenous antihypertensive agents based on patient characteristics are key to minimizing end-organ damage in hypertensive emergencies.

Cite This Study

Rhoney et al. (2009) studied this question.

synapsesocial.com/papers/6a7255fbfebe604dd70a8cab https://doi.org/10.2146/ajhp080348.p2

Topics

Hypertension management

View Full Paper

Ask AI

Bookmark

Implication

Emphasizes pharmacology- and comorbidity-driven IV antihypertensive choice in hypertensive emergencies; leaves open definitive outcome data from randomized studies.

Intravenous therapy for hypertensive emergencies, part 2

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Topics

Intravenous therapy for hypertensive emergencies, part 2

Discussion

Member takes

Implication

Structured PICO

Cite This Study

Also Consider

Topics

Also Consider